• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食用真菌多糖、肠道微生物群与宿主健康。

Edible fungal polysaccharides, the gut microbiota, and host health.

机构信息

College of Food Science and Engineering, Northwest A&F University, Yangling, Shaanxi 712100, China.

College of Food Science and Engineering, Northwest A&F University, Yangling, Shaanxi 712100, China.

出版信息

Carbohydr Polym. 2021 Dec 1;273:118558. doi: 10.1016/j.carbpol.2021.118558. Epub 2021 Aug 14.

DOI:10.1016/j.carbpol.2021.118558
PMID:34560969
Abstract

The plasticity of the gut microbiota (GM) creates an opportunity to reshape the biological output of gut microbes by manipulating external factors. It is well known that edible fungal polysaccharides (EFPs) can reach the distal intestine and be assimilated to reshape the GM. The GM has unique devices that utilize various EFPs and produce oligosaccharides, which can selectively promote the growth of beneficial bacteria and are fermented into short-chain fatty acids that interact closely with intestinal cells. Here we review EFPs-based interventions for the GM, particularly the key microorganisms, functions, and metabolites. In addition, we discuss the bi-directional causality between GM imbalance and diseases, and the beneficial effects of EFPs on host health via GM. This review can offer a valuable reference for the design of edible fungal polysaccharide- or oligosaccharide-based nutrition interventions or drug development for maintaining human health by targeted regulation of the GM.

摘要

肠道微生物群(GM)的可塑性为通过操纵外部因素来重塑肠道微生物的生物学输出创造了机会。众所周知,食用真菌多糖(EFPs)可以到达远端肠道并被吸收,从而重塑 GM。GM 具有独特的装置,可以利用各种 EFPs 并产生寡糖,这些寡糖可以选择性地促进有益细菌的生长,并发酵成短链脂肪酸,与肠道细胞密切相互作用。在这里,我们综述了基于 EFPs 的 GM 干预措施,特别是关键微生物、功能和代谢物。此外,我们还讨论了 GM 失衡与疾病之间的双向因果关系,以及 EFPs 通过 GM 对宿主健康的有益影响。本综述可为设计基于食用真菌多糖或寡糖的营养干预措施或药物开发提供有价值的参考,通过靶向调节 GM 来维持人类健康。

相似文献

1
Edible fungal polysaccharides, the gut microbiota, and host health.食用真菌多糖、肠道微生物群与宿主健康。
Carbohydr Polym. 2021 Dec 1;273:118558. doi: 10.1016/j.carbpol.2021.118558. Epub 2021 Aug 14.
2
Edible herbal source-derived polysaccharides as potential prebiotics: Composition, structure, gut microbiota regulation, and its related health effects.食用草药源衍生多糖作为潜在的益生元:组成、结构、肠道微生物群调节及其相关的健康影响。
Food Chem. 2024 Nov 15;458:140267. doi: 10.1016/j.foodchem.2024.140267. Epub 2024 Jun 28.
3
Modulatory effects of polysaccharides from plants, marine algae and edible mushrooms on gut microbiota and related health benefits: A review.植物、海藻和食用菌多糖对肠道微生物群的调节作用及相关健康益处:综述
Int J Biol Macromol. 2022 Apr 15;204:169-192. doi: 10.1016/j.ijbiomac.2022.01.166. Epub 2022 Feb 2.
4
Selective impact of three homogenous polysaccharides with different structural characteristics from Grifola frondosa on human gut microbial composition and the structure-activity relationship.灰树花子实体中三种结构特征不同的均一多糖对人类肠道微生物组成的选择性影响及结构-活性关系。
Int J Biol Macromol. 2024 Jun;269(Pt 2):132143. doi: 10.1016/j.ijbiomac.2024.132143. Epub 2024 May 8.
5
A unique polysaccharide from Hericium erinaceus mycelium ameliorates acetic acid-induced ulcerative colitis rats by modulating the composition of the gut microbiota, short chain fatty acids levels and GPR41/43 respectors.从猴头菇菌丝体中提取的一种独特多糖通过调节肠道微生物群落组成、短链脂肪酸水平和 GPR41/43 受体,改善乙酸诱导的溃疡性结肠炎大鼠。
Int Immunopharmacol. 2019 Jun;71:411-422. doi: 10.1016/j.intimp.2019.02.038. Epub 2019 May 3.
6
Prebiotics and the Human Gut Microbiota: From Breakdown Mechanisms to the Impact on Metabolic Health.益生元和人类肠道微生物群:从分解机制到对代谢健康的影响。
Nutrients. 2022 May 17;14(10):2096. doi: 10.3390/nu14102096.
7
Wood-Derived Dietary Fibers Promote Beneficial Human Gut Microbiota.木质膳食纤维促进有益的人类肠道微生物群。
mSphere. 2019 Jan 23;4(1):e00554-18. doi: 10.1128/mSphere.00554-18.
8
Gut bacterial metabolites of indigestible polysaccharides in intestinal fermentation as mediators of public health.肠道发酵中不可消化多糖的肠道细菌代谢产物作为公共卫生的介质。
Bratisl Lek Listy. 2019;120(11):807-812. doi: 10.4149/BLL_2019_134.
9
Anti-aging potency correlates with metabolites from fermentation of edible fungal polysaccharides using human fecal intestinal microflora.抗老化功效与食用真菌多糖经人体肠道微生物发酵后的代谢产物相关。
Food Funct. 2022 Nov 14;13(22):11592-11603. doi: 10.1039/d2fo01951e.
10
Review of the relationships among polysaccharides, gut microbiota, and human health.多糖、肠道微生物群与人类健康关系的研究综述。
Food Res Int. 2021 Feb;140:109858. doi: 10.1016/j.foodres.2020.109858. Epub 2020 Nov 2.

引用本文的文献

1
Bioactive Polysaccharides Prevent Lipopolysaccharide-Induced Intestinal Inflammation via Immunomodulation, Antioxidant Activity, and Microbiota Regulation.生物活性多糖通过免疫调节、抗氧化活性和微生物群调节预防脂多糖诱导的肠道炎症。
Foods. 2025 Jul 23;14(15):2575. doi: 10.3390/foods14152575.
2
Restoration of antibiotic associated diarrhea induced gut microbiota disorder by using water-insoluble polysaccharides in C57BL/6J mice.使用水不溶性多糖恢复C57BL/6J小鼠抗生素相关性腹泻诱导的肠道微生物群紊乱
Front Nutr. 2025 Jul 10;12:1607365. doi: 10.3389/fnut.2025.1607365. eCollection 2025.
3
A randomised trial of pleuran in paediatric acute gastroenteritis.
小儿急性肠胃炎中使用普卢兰的随机试验。
Sci Rep. 2025 May 15;15(1):16912. doi: 10.1038/s41598-025-94893-3.
4
Understanding the complex function of gut microbiota: its impact on the pathogenesis of obesity and beyond: a comprehensive review.理解肠道微生物群的复杂功能:其对肥胖及其他疾病发病机制的影响:综述
Diabetol Metab Syndr. 2024 Dec 23;16(1):308. doi: 10.1186/s13098-024-01561-z.
5
Plant polysaccharides and antioxidant benefits for exercise performance and gut health: from molecular pathways to clinic.植物多糖及其对运动表现和肠道健康的抗氧化益处:从分子途径到临床
Mol Cell Biochem. 2025 May;480(5):2827-2846. doi: 10.1007/s11010-024-05178-8. Epub 2024 Dec 18.
6
Characterization of the gut microbiota and fecal metabolome in the osteosarcoma mouse model.骨癌小鼠模型中肠道微生物群和粪便代谢组的特征。
Aging (Albany NY). 2024 Jul 3;16(13):10841-10859. doi: 10.18632/aging.205951.
7
Therapeutic Potential of Fungal Polysaccharides in Gut Microbiota Regulation: Implications for Diabetes, Neurodegeneration, and Oncology.真菌多糖在肠道微生物群调节中的治疗潜力:对糖尿病、神经退行性疾病和肿瘤学的影响
J Fungi (Basel). 2024 May 31;10(6):394. doi: 10.3390/jof10060394.
8
Updated Progress on Polysaccharides with Anti-Diabetic Effects through the Regulation of Gut Microbiota: Sources, Mechanisms, and Structure-Activity Relationships.通过调节肠道菌群发挥抗糖尿病作用的多糖研究进展:来源、作用机制及构效关系
Pharmaceuticals (Basel). 2024 Apr 2;17(4):456. doi: 10.3390/ph17040456.
9
microcapsules prepared from okra polysaccharides improved intestinal microbiota in Alzheimer's disease mice.由秋葵多糖制备的微胶囊改善了阿尔茨海默病小鼠的肠道微生物群。
Front Microbiol. 2024 Mar 18;15:1305617. doi: 10.3389/fmicb.2024.1305617. eCollection 2024.
10
Dietary habits, physical activity, and self-reported rhinosinusitis in children and adolescents.饮食行为、身体活动与儿童和青少年自述的鼻-鼻窦炎。
Front Public Health. 2024 Jan 8;11:1290307. doi: 10.3389/fpubh.2023.1290307. eCollection 2023.